Open AccessThe Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention
Author(s) -
Yuhan Qin,
Qiao Ye,
Dong Wang,
Gaoliang Yan,
Chengchun Tang,
Genshan Ma
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s339075
Subject(s) - supar , medicine , acute kidney injury , percutaneous coronary intervention , conventional pci , creatinine , renal function , receiver operating characteristic , biomarker , cardiology , gastroenterology , urokinase , myocardial infarction , urokinase receptor , biochemistry , chemistry
Soluble urokinase-type plasminogen activator receptor (SuPAR) is a circulating protein and a novel identified promising biomarker for various renal diseases and kidney injury. However, it remains unknown on the predictive value of suPAR in contrast induced acute kidney injury (CI-AKI) in patients undergoing percutaneous coronary intervention (PCI).